Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Nanotechnology, PLGA Nanoparticles Controlled Release

Robert Langer

ScD

🏢Massachusetts Institute of Technology🌐USA

David H. Koch Institute Professor

136
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Robert Langer is among the most influential biomedical engineers in history, having founded the field of controlled drug release from polymer matrices. His research on PLGA and other biodegradable polymer nanoparticles has underpinned dozens of cancer drug delivery platforms. He co-founded more than 40 biotechnology companies, including those developing nanoparticle cancer drug delivery systems, and has contributed to the scientific foundation for lipid nanoparticle mRNA vaccines.

Share:

🧪Research Fields 研究领域

PLGA polymer controlled drug release
nanoparticle cancer sustained release
MIT Koch Institute nanomedicine
polymer biomaterials drug delivery
targeted cancer nanoparticle platforms

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Robert Langer 的研究动态

Follow Robert Langer's research updates

留下邮箱,当我们发布与 Robert Langer(Massachusetts Institute of Technology)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment